On November 18, Doximity, Inc. fell 5.29% in Regular Trading, trading at $31.035 per share, with turnover of $23.7073 million.
The move followed a short-term pullback after recent earnings and partnership-related positives had already been reflected in the share price.
Earlier this month, Doximity, Inc. reported fiscal Q2 adjusted earnings of $0.36 per share versus the $0.35 consensus, with revenue of $174.5 million above the $170.8 million expectation, and raised fiscal revenue guidance to $678 million-$683 million from a consensus near $677.6 million. Analyst target prices were also lifted, including RBC to $34 and Barclays to $30, while the stock had gained 35.97% over the past 90 days. With the shares near the broader average target price of about $31.47, the latest decline suggests the recent rally is consolidating after favorable developments.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)